KMT2D and PIK3CA mutation as potential factors to predict adjuvant chemotherapy efficacy in surgical triple negative breast cancer.Xue Wang,Feng Du,Jian Yue,Yiran Si,Lina Cui,Bei Zhang,Xiaochen Zhao,Binghe Xu,Peng YuanCANCER RESEARCH(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要